15 October 2019
Visiongain has launched a new pharma report ‘’Medical Oxygen Concentrators Market Report 2020-2030’’ Prospects by Product (Portable Oxygen Concentrators, Stationary Oxygen Concentrators), Technology (Continuous Flow, Pulse Dose), Application (Homecare, Non-Homecare), and Geography
Global medical oxygen concentrators market is anticipated to grow on account of the increasing incidence of chronic obstructive pulmonary disease (COPD). The global medical oxygen concentrators market is anticipated to grow at a lucrative CAGR of 8.4% and anticipated to surpass USD 4 Billion by 2030.
The increasing incidence of chronic obstructive pulmonary disease (COPD) combined with the increasing number of smokers will drive the global medical oxygen concentrators market. Increasing smoke and dust manufacturing in multiple industrial sectors will be the main influencing factor in the medical oxygen concentrations industry. Moreover, the growing elderly population, susceptible to multiple respiratory disorders, will further boost the development of businesses for medical oxygen concentrations across the globe.
For patients with COPD, serious chronic hypoxemia and pulmonary edema, medical oxygen concentrators provide additional oxygen. They can be used in combination with a continuous positive airway pressure device as an additional therapy for serious sleep apnea. Typically, oxygen concentrators are used as stationary sources to provide patients at home with long-term oxygen therapy (LTOT).
Based on type, portable oxygen concentrators dominated the general industry in 2018 and accounted for over 40% of the global revenue due to factors such as growing geriatric population, increased COPD incidence, and growing demand for home health oxygen therapy.
The medical oxygen concentrator market was dominated by North America in 2018 and the trend is the same over the forecast period. Well-established health infrastructure; the existence of major players; increasing awareness of sophisticated techniques of therapy are the main driving factors in the region for this industry. During the forecast period, the Asian medical oxygen concentrator market is anticipated to grow with the highest CAGR due to improved healthcare industry; increased COPD and asthma incidence; and the existence of emerging countries such as China and India.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations and launching new products to strengthen their position in the global medical oxygen concentrators market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the market.
The comprehensive market report features companies such as AirSep, Besco Medical Co. Ltd.,
Chart Industries, Covidien, DeVilbiss Healthcare, GCE Group, Inogen, Inova Labs, Invacare, Koninklijke Philips N.V., Nidek Medical, O2 Concepts, Philips Respironics, Precision Medical, Inc., Teijen among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020–2030 for global markets such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Benelux, Russia, Poland, India, Japan, China, Australia, ASEAN, GCC, South Africa and North Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Due to increases in the therapies in progress, the dosages provided, & the patient populations targeted, viral vector production capacity has become increasingly reduced in recent years. The condition is aggravated by COVID-19.
03 December 2020
Drugs Abuse has risen very significantly in few last year as compared to previous once and expected to continuously rise over the forecast period. The increase in the drugs abuse creates a huge demand for the drugs of abuse testing products.
03 December 2020
Continuous increasing prevalence of chronic pain is increasing demand for controlled substance as treatment for Chronic pain. Due to which increasing prevalence of chronic pain around the world is working as a driver for the controlled substance market.
03 December 2020
All regions are facing rapid growth in the companion animal population. Companion animal are at high risk of developing various diseases for which companion animal require timely diagnosis for the identification, detection and treatment for life causing diseases.